Joseph Kakkis

Joseph Kakkis has a diverse work experience in various sectors. Joseph is currently working as an Associate Researcher at the Icahn School of Medicine at Mount Sinai since July 2022. Prior to this, they served as the Head of Development at a company in stealth mode starting in April 2022. In November 2020, they were the Head of Outreach and Advisor at the Altrui Foundation. From September 2019 onwards, they held the position of Head of Fundraising & Treasurer at First Generation Investors, where they taught high school students in underserved communities about long-term investing. In addition, from June 2021 to May 2022, they worked as a Venture Investor in the biotech space at F-Prime Capital. Joseph was also a Student Researcher at the Center for Cytokine Storm Treatment and Laboratory, where they conducted research on Castleman disease and worked on the CORONA Project. Lastly, they worked as a Research Analyst at the Gene Therapy Program at the University of Pennsylvania, where they analyzed tissue samples in a preclinical study.

Joseph Kakkis pursued their Bachelor's degree in Biology with a concentration in Mechanisms of Disease from the University of Pennsylvania, starting in 2018 and completing in 2021. Prior to that, in 2017 and 2018, they attended New York University, although no specific degree or field of study information is provided for that period.